Literature DB >> 11279684

Repeated lumbar or ventricular punctures in newborns with intraventricular hemorrhage.

A Whitelaw1.   

Abstract

BACKGROUND: Although it has been possible to reduce the percentage of premature infants suffering intraventricular hemorrhage, posthemorrhagic hydrocephalus remains a serious problem without a good treatment. There is a high rate of cerebral palsy, and ventriculoperitoneal shunt surgery makes the child permanently dependent on the valve and catheter system. Shunt surgery cannot be carried out early because of the blood in the cerebrospinal fluid (CSF) and the brain may be subjected to periods of raised pressure. Early tapping of CSF by lumbar puncture or ventricular tap was suggested as a way of temporarily reducing pressure and removing blood and protein and thereby avoiding permanent hydrocephalus.
OBJECTIVES: To determine whether repeated CSF tapping, by lumbar puncture or ventricular tap, reduced the risk of permanent shunt dependence, neurodevelopmental disability or death in neonates at risk of, or actually developing, post-hemorrhagic hydrocephalus (PHH). This form of treatment was based on the hypothesis that repeated tapping removed protein and blood from the CSF, thus clearing obstruction from the channels of CSF absorption. SEARCH STRATEGY: Pediatric, Neurosurgical and General Medical Journals were handsearched from 1976 up to October 2000, as well as the Medline database (via PubMed) and the Cochrane Controlled Trials Register. Personal contacts were used. SELECTION CRITERIA: Four controlled trials ( with five published papers) were identified, three being randomised and the fourth using alternative allocation. Two trials evaluated repeated lumbar punctures in neonates with intraventricular hemorrhage (IVH) and two trials evaluated repeated CSF tapping infants with IVH followed by progressive ventricular dilatation. DATA COLLECTION AND ANALYSIS: In addition to details of the patient selection and patient allocation, the interventions were extracted. The end-points examined were: ventriculoperitoneal shunt, death, disability, multiple disability and death or disability. MAIN
RESULTS: The studies were sufficiently similar in the question they were asking and the interventions were sufficiently in common that they could be combined when assessing the effect of the intervention. When repeated CSF tapping was compared to conservative treatment, the relative risks for shunt placement, death, disability and multiple disability were very close to 1.0 with no statistically significant effect. There is also evidence that this form of treatment increased the risk of CSF infection. REVIEWER'S
CONCLUSIONS: Early repeated CSF tapping cannot be recommended for neonates at risk of, or actually developing, post-hemorrhagic hydrocephalus.

Entities:  

Mesh:

Year:  2001        PMID: 11279684     DOI: 10.1002/14651858.CD000216

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  21 in total

1.  Incidence of infections of ventricular reservoirs in the treatment of post-haemorrhagic ventricular dilatation: a retrospective study (1992-2003).

Authors:  A J Brouwer; F Groenendaal; A van den Hoogen; M Verboon-Maciolek; P Hanlo; K J Rademaker; L S de Vries
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-06-05       Impact factor: 5.747

Review 2.  Diuretics in pediatrics : current knowledge and future prospects.

Authors:  Maria M J van der Vorst; Joana E Kist; Albert J van der Heijden; Jacobus Burggraaf
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

3.  A multicenter retrospective comparison of conversion from temporary to permanent cerebrospinal fluid diversion in very low birth weight infants with posthemorrhagic hydrocephalus.

Authors:  John C Wellons; Chevis N Shannon; Abhaya V Kulkarni; Tamara D Simon; Jay Riva-Cambrin; William E Whitehead; W Jerry Oakes; James M Drake; Thomas G Luerssen; Marion L Walker; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2009-07       Impact factor: 2.375

Review 4.  Neonatal brain hemorrhage (NBH) of prematurity: translational mechanisms of the vascular-neural network.

Authors:  Tim Lekic; Damon Klebe; Roy Poblete; Paul R Krafft; William B Rolland; Jiping Tang; John H Zhang
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 5.  Neonatal posthemorrhagic hydrocephalus from prematurity: pathophysiology and current treatment concepts.

Authors:  Shenandoah Robinson
Journal:  J Neurosurg Pediatr       Date:  2012-03       Impact factor: 2.375

6.  Posthemorrhagic ventricular dilatation in preterm infants: When best to intervene?

Authors:  Lara M Leijser; Steven P Miller; Gerda van Wezel-Meijler; Annemieke J Brouwer; Jeffrey Traubici; Ingrid C van Haastert; Hilary E Whyte; Floris Groenendaal; Abhaya V Kulkarni; Kuo S Han; Peter A Woerdeman; Paige T Church; Edmond N Kelly; Henrica L M van Straaten; Linh G Ly; Linda S de Vries
Journal:  Neurology       Date:  2018-01-24       Impact factor: 9.910

7.  Incidence of hydrocephalus and the need to ventriculoperitoneal shunting in premature infants with intraventricular hemorrhage: risk factors and outcome.

Authors:  Shahin Behjati; Parisa Emami-Naeini; Farideh Nejat; Mostafa El Khashab
Journal:  Childs Nerv Syst       Date:  2011-01-14       Impact factor: 1.475

Review 8.  Infantile posthemorrhagic hydrocephalus.

Authors:  Vasilios Tsitouras; Spyros Sgouros
Journal:  Childs Nerv Syst       Date:  2011-09-17       Impact factor: 1.475

9.  Endoscopic neurosurgery in preterm and term newborn infants--a feasibility report.

Authors:  Matthias Schulz; Christoph Bührer; Birgit Spors; Hannes Haberl; Ulrich-Wilhelm Thomale
Journal:  Childs Nerv Syst       Date:  2012-12-29       Impact factor: 1.475

Review 10.  Ventriculoperitoneal shunt as a primary neurosurgical procedure in newborn posthemorrhagic hydrocephalus: report of a series of 47 shunted patients.

Authors:  L Romero; B Ros; F Ríus; L González; J M Medina; A Martín; A Carrasco; M A Arráez
Journal:  Childs Nerv Syst       Date:  2013-07-24       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.